Form 4: Cencora Director Redonda Miller Receives Restricted Stock Units

Director Redonda Miller acquired 843 shares of Cencora, Inc. through a restricted stock unit grant.

Summary

• On March 12, 2024, Redonda Miller, a director of Cencora, Inc., acquired 843 shares of common stock through a grant of restricted stock units.
• These restricted stock units vest 100% on the first anniversary of the grant date.
• Delivery of the vested shares is deferred until January 3, 2029.
• Following the transaction, Miller directly owns 2,405 shares of Cencora common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of restricted stock units is a standard practice and indicates alignment of interests between the director and shareholders. The deferred delivery suggests a long-term commitment.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
• Deferred delivery of shares until 2029 suggests a long-term commitment to the company's success.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This type of stock grant is a common practice for compensating and incentivizing directors in publicly traded companies within the pharmaceutical distribution industry.

Comparison to Industry Standards

• Stock grants to directors are a standard practice across the pharmaceutical distribution industry.
• Companies like McKesson and Cardinal Health also utilize stock grants as part of their director compensation packages.
• The vesting schedule and deferral of delivery are typical features designed to align director interests with long-term shareholder value.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The grant has a negligible impact on employees, customers, suppliers, and creditors.

Key Dates